🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

HCM cardiologist wanted - NYU Langone Health Hypertrophic Cardiomyopathy Program is hiring Apply here ⬇️ careers.acc.org/job/hypertroph…

How common is hypertrophic cardiomyopathy… really? Thoughts on the prevalence question & making sense of disparate data. sciencedirect.com/science/articl… Martin Maron, MD Ethan Rowin @4hcm Ahmad Masri Matthew W Martinez HCMBeat NYU Langone Health NYU Grossman School of Medicine

ICYMI: 95% of patients with hypertrophic #cardiomyopathy and apical aneurysms have mid-ventricular obstruction. bit.ly/3noxgWm #echofirst #cvHCM #JACCIMG

#RCM - Vol. 24 No. 5 🪘Review Acute Left Ventricular Ballooning: Tools to Differentiate Hypertrophic Cardiomyopathy with Outflow Obstruction from Neurohumoral Takotsubo Syndrome 📒Arushi Singh, Louai Razzouk, MD MPH, Daniele Massera, Mark V. Sherrid #HCM #TTS 📢 imrpress.com/journal/RCM/24…

We are recruiting for an HCM attending cardiologist position at the NYU Langone Hypertrophic Cardiomyopathy Program. Information & apply here: careers.acc.org/job/hcm-attend…

Registration open for the 3rd Critical Care Cardiology Symposium NYU Langone Health!! NYC Health + Hospitals/Bellevue 🔥 Now expanded 1.5 days! 🔥CardioNerds poster session! 🔥FIT Mentoring lunch 🔥 Crit care skills Sim session 🔥Endorsed by 5 ACC chapters! #critcarecards23 Nyulmc.org/critcarecardsc…

Congrats to this year's Critical Care Cardiology Symp course directors & faculty. An excellent line-up on advances in care for pts with acute CV issues! Daniele Massera Stephanie Golob Carlos L. Alviar MD, FACC Christopher Barnett MD, MPH, FACC Samuel Bernard Ann Gage James Horowitz Jason N. Katz Eugene Yuriditsky

📢 Registration is officially OPEN for #HCMSummit8!📷 Join us in Boston 1 year from today (Oct 25-27, 2024). Register early & save $100 on tickets now through Dec 31. Visit hcmsummit.org for details & follow The International HCM Summit for event updates. #hcm #hypertrophiccardiomyopathy

We are recruiting for an HCM attending cardiologist position at the NYU Langone Health Hypertrophic Cardiomyopathy Program. Information & apply here: jobs.nyulangone.org/job/17542344/h…

‼️ Our #review on #HCM + #HTN is out 🔸 knowledge/evidence gaps r/t BP targets/management & person-centered outcomes ➡️ future investigation ⁦Maria Reuter⁩ ⁦Daniele Massera⁩ ⁦Daichi Shimbo MD⁩ ⁦@4hcm⁩ ⁦Hypertrophic Cardiomyopathy Medical Society⁩ ⁦HCMBeat⁩ sciencedirect.com/science/articl…

#ACC24 #JACC LBCT SimPub: IMPROVE-HCM - targeting myocardial energetics with novel mitotrope drug, #ninerafaxstat, was safe and improved exercise capacity and symptoms in nonobstructive HCM. bit.ly/3U7VxO2 #cvHCM Martin Maron, MD Betty Raman Daniele Massera SharonCresciMD

Mitral Leaflet Shortening as an Ancillary Procedure in Obstructive Hypertrophic Cardiomyopathy - The Annals of Thoracic Surgery annalsthoracicsurgery.org/article/S0003-…

IMPROVE-HCM: Targeting myocardial energetics with a novel mitotrope drug, #ninerafaxstat, was safe and improved exercise capacity and symptoms in nonobstructive #HCM. bit.ly/3wL3jok #JACC #cvHCM Betty Raman Daniele Massera SharonCresciMD Matthew W Martinez Martin Maron, MD

🚨Just 4 months away! Join us at the @hcmsummit in Boston (Oct 25-27). Hear from these 45 internationally renowned specialists at the definitive global scientific meeting on #hypertrophiccardiomyopathy. Tickets: hcmsummit.org. #cardiotwitter #cardioed #hcmsummit8 #hcm

🍝Eating before resting and 🏃stress echo unmasked left ventricular outflow obstruction ≥50 mmHg in 35% of #HCM patients believed to have no significant obstruction. Check out our new data in JASE #CardioTwitter #Echofirst NYU Langone Health onlinejase.com/article/S0894-…

To everyone who joined us, THANK YOU. What a fantastic weekend. Enjoy our highlight reel featuring A/Prof Jodie Ingles Daniele Massera Lisa Flanigan Salberg Michelle Kittleson MD PhD Ntobeko Ntusi Mariko Harper MD MS iacopo olivotto #barrymaron Hisham Ahamed MD DM. (Full reel: hcmsummit.org.) #hcmsummit8

Disopyramide for long-term treatment of obstructive #hcm? Check out our work looking at patients treated for ≥5 years at NYU Langone Health Lahey Hospital with 67% still on drug after ~7 years Ethan Rowin Martin Maron, MD ahajournals.org/doi/full/10.11…

Disopyramide appears safe and effective in treating symptomatic outflow obstruction in HCM over extended durations of time (≥5 years). #AHAJournals Daniele Massera NYU Langone Health Ethan Rowin Lahey Hospital ahajrnls.org/4hC5AnC